Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
about
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapyEvidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.Progression of HIV in haemophilia.The contribution of viral genotype to plasma viral set-point in HIV infectionKinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, KenyaComparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.Delays in protease inhibitor use in clinical practiceRisk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in NigeriaSelection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia.Recent advances. General medicine.Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission.Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replicationHIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.Development of a contemporary globally diverse HIV viral panel by the EQAPOL programThe clinical utility of viral load monitoring in HIV infection: strengths and limitationsStructured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.The potential role of biomarkers in HIV preventive vaccine trialsAntiretroviral therapy for human immunodeficiency virus infection in 1997.Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses.Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA loadHigh levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialValidation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.Viral load as a surrogate end point in HIV disease.Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns.Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection.Human retroviruses after 20 years: a perspective from the past and prospects for their future control.The recombinant maize ribosome-inactivating protein transiently reduces viral load in SHIV89.6 infected Chinese Rhesus Macaques.Can we predict the prognosis of HIV infection? How to use the findings of a prospective studyA simple relationship between viral load and survival time in HIV-1 infection.HIV-1: maternal prognosis.
P2860
Q24531479-BF7946CF-DC11-46B2-8216-75C292107E9DQ24798930-78B9D4C2-3FA4-46BC-8B78-8FE05B339717Q24815966-02BA9509-CDB2-4CFC-8557-8E9FA4E5A28AQ30372415-1932D70B-00E4-4357-BB56-38F211840788Q33504805-1701FC27-8282-45CF-A8CF-5C17CA442D74Q33553778-C87609D7-594F-4DA9-BCDD-7CB42B595BE4Q33641801-2F3C884A-98AE-4E7E-BAD8-1F22CB02DE24Q33648259-69FE2132-4CA3-4AC0-9C39-5CDF5DD823A6Q33686223-ACC2B74D-EDDC-495B-B05E-6AFCAA22BCFEQ33694010-EAD092EB-17AF-45EA-B8FD-76F3A01A711DQ33764938-ACA382A6-3DB1-4327-94E4-2ABD5A466592Q33780649-01D08AAE-1AAB-4187-BFA4-E78CA9461020Q33783429-285E83C0-5B6D-4708-9224-9D20E9A8D91BQ33791941-E9F49721-2515-46B2-8F71-BB8EA0585576Q33806110-E94D59B6-5E78-4BAB-AEAC-66546FFE01A7Q33811266-70167309-266B-4EB5-9472-8BAA69B8F8E0Q33853859-E7FDB790-D815-4F37-906A-88DE790AB6E5Q33922689-971870AF-AED7-4ACB-BAC5-51B23FE2A649Q33936351-D4F24187-A140-4008-A274-E7B716C34FF7Q33949316-6D5FC472-5024-45E6-9C6C-2DA681321F43Q33968241-BA6A670C-F975-4685-BBAA-FE0F00793832Q34059957-E6F9D14A-03DE-4050-BA8A-AD066760DCA3Q34185841-BB2FC14B-82C7-4B9E-9C92-F221C40F249DQ34315612-1A6EE723-27D9-4AFC-9F8B-D694E1BD7EFDQ34333167-99647730-C5D1-4DC2-A10F-7AB7E552CB5BQ34348055-DB572B52-B9AB-4509-9FFD-216879AB64A8Q34348128-724113BE-57A9-46B0-A523-D91355B5A9BCQ34351301-8B22CFEB-15A9-495A-87ED-6F52DAAD6C01Q34408313-55C5C4D6-B465-483B-8583-BE866B468ABFQ34437099-6ACE5B84-4AB0-4EFD-A23A-520E7DDB1748Q34533854-7ABAD6D0-6379-489B-B688-FB571D05050CQ34553778-0917510C-7975-4159-8E72-79F7F865F475Q34573789-0E1D533C-EC06-4F94-9632-8FED094A659BQ34701418-922F14B1-A9BF-43B7-808D-A54FD125B6B2Q34772982-37372A35-0EBE-47F2-9CDA-90573853D849Q34792498-22FAE8E7-D204-44E4-9612-7E83626F4A85Q35003689-D5575005-D417-4380-9DE9-21497EDE76C7Q35562091-CFFB1D7B-B554-443D-9C44-BCD352F45D24Q35655811-F28FED05-9A40-4C7A-857F-440F33F0658EQ35695524-A24A03C6-E7DE-4901-88AE-CF57386686DD
P2860
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Serum HIV-1 RNA levels and tim ...... enter Hemophilia Cohort Study.
@en
type
label
Serum HIV-1 RNA levels and tim ...... enter Hemophilia Cohort Study.
@en
prefLabel
Serum HIV-1 RNA levels and tim ...... enter Hemophilia Cohort Study.
@en
P2093
P1476
Serum HIV-1 RNA levels and tim ...... enter Hemophilia Cohort Study.
@en
P2093
A Hatzakis
B L Kroner
J J Goedert
L M Aledort
M W Hilgartner
P S Rosenberg
P304
P356
10.1001/JAMA.1996.03540020027025
P407
P577
1996-07-01T00:00:00Z